Sorrento Therapeutics

Search
  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • COVID-19
    • Immunotherapy
    • Pain
    • Lymphatic Drug Delivery
    • Product Candidates
    • Clinical Trials
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC Filings
    • Stock
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Careers
  • Contact
en English▼
X
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sudanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu

8-K

tv479053_Sorrento-Therapeutics-Inc-8-K-AS-FILED

S-3

tv478890-Sorrento-Therapeutics-Inc-S-3-As-Filed

srne-20170930.xml

srne-20170930.xml

srne-20170930_pre.xml

srne-20170930_pre.xml

srne-20170930_lab.xml

srne-20170930_lab.xml

srne-20170930_def.xml

srne-20170930_def.xml

srne-20170930_cal.xml

srne-20170930_cal

10Q

FY17Q3-10-Q-Draft-v11-09-17-2am-AS-FILED

8 K

8-K-filed-on-10-6-17

S 3

S 3 filed on 10-5-17

© 2023 Sorrento Therapeutics, Inc. All Rights Reserved. Terms of Use | Forward Looking Statements | Privacy Policy | Cookie Policy | Notices
logo
  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • COVID-19
    • Immunotherapy
    • Pain
    • Lymphatic Drug Delivery
    • Product Candidates
    • Clinical Trials
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC Filings
    • Stock
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Careers
  • Contact